All Stories

  1. ANMCO Position Paper: long-term follow-up of patients with pulmonary thromboembolism
  2. The optimal duration of anticoagulant therapy after unprovoked venous thromboembolism – still a challenging issue
  3. Outcome after discontinuing anticoagulant therapy in women with venous thromboembolism during hormonal use
  4. Are too many inferior vena cava filters used? Controversial evidences in different clinical settings: a narrative review
  5. Intima-media thickness remodelling in hypertensive subjects with long-term well-controlled blood pressure levels
  6. Residual pulmonary obstruction and the risk of late complications in patients with pulmonary embolism
  7. Are direct oral anticoagulants equally effective in reducing deep vein thrombosis and pulmonary embolism?
  8. Incidence of Arterial Embolism in Patients on Treatment with Old and New Anticoagulants for Venous Thromboembolism
  9. The Impact of Residual Thrombosis on the Long-Term Outcome of Patients with Deep Venous Thrombosis Treated with Conventional Anticoagulation
  10. Fondaparinux in the initial and long-term treatment of venous thromboembolism
  11. Prevention and treatment of the post-thrombotic syndrome and of the chronic thromboembolic pulmonary hypertension
  12. Further evidence in support of the association between venous thrombosis and atherosclerosis: A case–control study
  13. The value of inhibitors of factor Xa for the treatment of pulmonary embolism
  14. Comparison of four scores to predict major bleeding in patients receiving anticoagulation for venous thromboembolism: findings from the RIETE registry
  15. Unexpectedly High Recanalization Rate in Patients with Pulmonary Embolism Treated with Anticoagulants Alone
  16. C0089: Unexpectedly High Recanalization Rate in Patients with Pulmonary Embolism Treated with Anticoagulants Alone
  17. The risk of recurrent thromboembolic disorders in patients with unprovoked venous thromboembolism: New scenarios and opportunities
  18. Residual vein thrombosis and trans-popliteal reflux in patients with and without the post-thrombotic syndrome
  19. An international survey on isolated subsegmental pulmonary embolism
  20. Diagnosis and treatment of pulmonary embolism: a multidisciplinary approach
  21. Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding
  22. Venous Thromboembolism and Arterial Complications
  23. Heart Disease May Be a Risk Factor for Pulmonary Embolism Without Peripheral Deep Venous Thrombosis
  24. The value of 64-detector row computed tomography for the exclusion of pulmonary embolism
  25. Major bleeding as a predictor of mortality in patients with venous thromboembolism: findings from the RIETE Registry
  26. Heart disease in patients with pulmonary embolism
  27. The postthrombotic syndrome
  28. Prevalence of heart diseases in patients with pulmonary embolism with and without peripheral venous thrombosis
  29. Risk stratification and outcomes in hemodynamically stable patients with acute pulmonary embolism: a prospective, multicentre, cohort study with three months of follow-up
  30. Duration of anticoagulation and risk of recurrent thromboembolism in carriers of factor V Leiden or prothrombin mutation
  31. Thrombophilia as a predictor of persistent residual vein thrombosis
  32. Metabolic syndrome and hyperhomocysteinemia in patients with deep vein thrombosis: a case-control study
  33. Immobilization resulting from chronic medical diseases: a new risk factor for recurrent venous thromboembolism in anticoagulated patients
  34. Quality of oral anticoagulant treatment and risk of subsequent recurrent thromboembolism in patients with deep vein thrombosis
  35. Endothelial dysfunction in patients with spontaneous venous thromboembolism
  36. D‐dimer as an adjunct to compression ultrasonography in patients with suspected recurrent deep vein thrombosis
  37. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients
  38. New Strategies for the Treatment of Acute Venous Thromboembolism
  39. The Value of Four-Detector Row Spiral Computed Tomography for the Diagnosis of Pulmonary Embolism
  40. Postthrombotic Syndrome
  41. Upper Extremity Deep Venous Thrombosis
  42. The metabolic syndrome and the risk of venous thrombosis: a case–control study
  43. Venous thromboembolism and the risk of subsequent symptomatic atherosclerosis
  44. Incidence of Chronic Thromboembolic Pulmonary Hypertension After a First Episode of Pulmonary Embolism
  45. Mo-P1:127 Venous thromboembolism and the risk of subsequent symptomatic atherosclerosis
  46. The Characteristics of the Thrombi of the Lower Limbs, as Detected by Ultrasonic Scanning, Do Not Predict Pulmonary Embolism
  47. Prevalence, Clinical Features, and Acute Course of Atypical Myocardial Infarction